DR. KARISSA HAMMER NOW ACCEPTING NEW PATIENTS AT INSTITUTE FOR HUMAN REPRODUCTION
30 Aug 2022
CHICAGO, Aug. 30, 2022 /PRNewswire/ -- The Institute for Human Reproduction (IHR) welcomes Dr. Karissa Hammer to their leading fertility practice headquartered in Chicago, IL with six locations throughout Chicagoland and Indiana. IHR is a member of Pinnacle Fertility, the fastest-growing network of physician-directed fertility practices in the US. Dr. Karissa Hammer is now accepting new patient consultations.
Continue Reading
Preview
Source: PRNewswire
Dr. Karissa Hammer
"I'm excited and honored to join the IHR team," shares Dr. Hammer. "IHR and Pinnacle Fertility's approach of collaboration and patient-first care is one that I wholeheartedly believe in. We have the best doctors in the world collectively working together to elevate science, technology, and treatment and provide our patients with a seamless journey and the best possible chance to build the families of their dreams."
Dr. Karissa Hammer is a board-eligible Reproductive Endocrinologist and Infertility Specialist who completed her fellowship in Reproductive Endocrinology and Infertility at Massachusetts General Hospital, Harvard Medical School. Prior to joining the IHR team, Dr. Hammer earned her bachelor's degree at Vanderbilt University, attended medical school at Rush University, and also completed her residency in Obstetrics and Gynecology at Rush University. She is board certified in Obstetrics and Gynecology.
Devoted to being an expert in her field, Dr. Hammer has contributed to 15 scientific publications and book chapters and has received numerous accolades for both her clinical skill and research while at Harvard. Her research interests include the impact of Anti-Mullerian hormone (AMH) on IVF outcomes, the impact of environmental and psychosocial influences on fertility, and effective methods for medical education in REI practice. She is one of the inaugural Surgical Scholars within the Society of Reproductive Surgeons and is passionate about minimally invasive surgical methods to preserve and enhance fertility.
Dr. Hammer provides comprehensive fertility services alongside the IHR physician team, including:
Fertility evaluation, diagnostic testing, and semen analysis
hysterosalpingogram (HSG),
Intrauterine Insemination (IUI)
in vitro fertilization (IVF),
Donor Sperm
Gestational Surrogacy
Embryo Donation and Adoption
LGBTQ+ family building
"We're thrilled to welcome Dr. Hammer to the IHR physician team," shares Dr. Ilan Tur-Kaspa, IHR's Founder and Co-Medical Director, "Her commitment and compassion for providing personalized fertility care align perfectly with our values at IHR and Pinnacle Fertility."
Patients may now schedule a new patient consultation with Dr. Karissa Hammer by submitting a request online or calling the office at (312) 288-6420.
About Institiute for Human Reproduction
Founded in 2004, Institute for Human Reproduction (IHR) is an industry-leading fertility center headquartered in Chicago, IL, that has provided comprehensive patient-centered care for two decades. Led by two world-renowned fertility specialists and visionaries, Dr. Ilan Tur-Kaspa and Dr. David Cohen, the IHR team is comprised of five physicians and six locations. IHR is passionate about finding success for growing families and prioritizing their patient's well-being on their journey every step of the way.
Visit IHRfertility.com to learn more about locations and services.
About Pinnacle Fertility
Pinnacle Fertility is the nation's fastest-growing physician-centric fertility care platform, supporting high-performing fertility clinics and comprehensive fertility service providers nationwide. Under a united mission of fulfilling dreams by building families, Pinnacle clinics offer innovative technology and processes, compassionate patient care, and comprehensive fertility treatment services, ensuring families receive a high-touch experience on their path to parenthood.
For more information about Pinnacle Fertility, visit pinnaclefertility.com
Contact:
Walt Conrad
[email protected]
SOURCE Pinnacle Fertility
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.